Medical News |
- FV Leiden mutation may influence sperm count
- Stroke prevalence ‘alarmingly high’ in Pakistan
- Childhood psoriasis common and a significant burden
- Treatment type and SES underlie racial disparity in prostate cancer survival
- Treatment type and SES underlie racial disparity in prostate cancer survival
- Prolonged exposure to passive smoke may increase breast cancer risk
- Intensive statin therapy improves PCI outcome in ACS patients
- Zinc supplements linked to HDL cholesterol decreases
- Sulphonylureas associated with higher risk for HF, death than metformin
- Prepregnancy overweight increases risk for diabetes and hypertension
- Analyses suggest rofecoxib risk evident 3 years before drug’s withdrawal
- Allogeneic mesenchymal stem cell therapy shows promise in AMI
- Sulphonylureas associated with higher risk for HF, death than metformin
- Intensive statin therapy improves PCI outcome in ACS patients
- Prolonged exposure to passive smoke may increase breast cancer risk
| FV Leiden mutation may influence sperm count Posted: 03 Dec 2009 04:00 PM PST Sperm count may explain the frequency of the factor V Leiden mutation in White individuals despite its association with pregnancy loss and venous thromboembolism, say Dutch researchers. |
| Stroke prevalence ‘alarmingly high’ in Pakistan Posted: 03 Dec 2009 04:00 PM PST The burden of cerebrovascular disease in Pakistan is "alarmingly high," with a lifetime stroke prevalence of around 20%, study findings suggest. |
| Childhood psoriasis common and a significant burden Posted: 03 Dec 2009 04:00 PM PST Psoriasis is common and associated with significant comorbidity in children, researchers have found. |
| Treatment type and SES underlie racial disparity in prostate cancer survival Posted: 03 Dec 2009 04:00 PM PST Prostate cancer patients have a higher risk for death if they are of low rather than high socioeconomic status, and have received nonsurgical rather than surgical treatment, report researchers. |
| Treatment type and SES underlie racial disparity in prostate cancer survival Posted: 03 Dec 2009 04:00 PM PST Prostate cancer patients have a higher risk for death if they are of low rather than high socioeconomic status, and have received nonsurgical rather than surgical treatment, report researchers. |
| Prolonged exposure to passive smoke may increase breast cancer risk Posted: 03 Dec 2009 04:00 PM PST Cumulative exposure to high levels of second-hand smoke may increase the risk for breast cancer in women who have never smoked cigarettes, US researchers report. |
| Intensive statin therapy improves PCI outcome in ACS patients Posted: 03 Dec 2009 04:00 PM PST Study results show that intensive statin therapy reduces the incidence of major adverse cardiovascular events in acute coronary syndrome patients who undergo percutaneous coronary intervention compared with treatment with moderate-dose statin therapy. |
| Zinc supplements linked to HDL cholesterol decreases Posted: 03 Dec 2009 04:00 PM PST Zinc supplements could increase the risk for coronary heart disease in healthy people by decreasing high-density lipoprotein cholesterol levels, researchers claim. |
| Sulphonylureas associated with higher risk for HF, death than metformin Posted: 03 Dec 2009 04:00 PM PST Treatment of patients with Type 2 diabetes with second-generation sulphonylureas significantly increases their risk for congestive heart failure compared with metformin therapy, show study results. |
| Prepregnancy overweight increases risk for diabetes and hypertension Posted: 03 Dec 2009 04:00 PM PST Researchers report that prepregnancy overweight is associated with significantly increased risks for subsequent diabetes and hypertension. |
| Analyses suggest rofecoxib risk evident 3 years before drug’s withdrawal Posted: 03 Dec 2009 04:00 PM PST Cumulative pooled analyses of clinical trials suggest that a significantly increased cardiovascular (CV) risk associated with rofecoxib use was evident by June 2001, 3 years before the drug was withdrawn from the market. |
| Allogeneic mesenchymal stem cell therapy shows promise in AMI Posted: 03 Dec 2009 04:00 PM PST A novel approach to cardiovascular stem cell therapy using allogeneic human mesenchymal stem cells has shown promise in a phase I study. |
| Sulphonylureas associated with higher risk for HF, death than metformin Posted: 03 Dec 2009 04:00 PM PST Treatment of patients with Type 2 diabetes with second-generation sulphonylureas significantly increases their risk for congestive heart failure compared with metformin therapy, show study results. |
| Intensive statin therapy improves PCI outcome in ACS patients Posted: 03 Dec 2009 04:00 PM PST Study results show that intensive statin therapy reduces the incidence of major adverse cardiovascular events in acute coronary syndrome patients who undergo percutaneous coronary intervention compared with treatment with moderate-dose statin therapy. |
| Prolonged exposure to passive smoke may increase breast cancer risk Posted: 03 Dec 2009 04:00 PM PST Cumulative exposure to high levels of second-hand smoke may increase the risk for breast cancer in women who have never smoked cigarettes, US researchers report. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment